ARA-290 (Cibinetide) 10mg — Repair. Restore. Recover.

Nerve Support | Tissue Repair | Recovery Research

Product Highlights

• 10mg ARA-290 (Cibinetide) lyophilised research peptide
• 11-amino-acid peptide derived from erythropoietin (EPO)
• Selectively targets the Innate Repair Receptor (IRR)
• Designed to support tissue protection without stimulating red blood cell production
• Manufactured in GMP-certified facilities to research-grade purity

Why ARA-290?

Recovery isn't just about healing muscle—it's about helping the body's natural repair systems respond to injury and inflammation.

ARA-290 is a synthetic peptide engineered from erythropoietin (EPO), specifically designed to retain EPO's tissue-protective properties while avoiding the stimulation of red blood cell production. Instead of targeting the classical EPO receptor, ARA-290 activates the Innate Repair Receptor (IRR), a pathway involved in tissue repair, inflammation resolution and nerve protection. Research has focused on its potential role in supporting nerve health, tissue recovery and reducing inflammatory responses.

Key Research Areas

? Nerve Health – Investigated for supporting nerve repair and regeneration in models of peripheral nerve injury and neuropathy.

? Inflammation Modulation – Studied for reducing inflammatory signalling while promoting tissue recovery.

? Tissue Protection – Research suggests activation of cellular pathways involved in protecting tissues from stress and injury.

⚡ Recovery Support – Explored for its potential to improve recovery following injury by supporting the body's innate repair mechanisms.

❤️ Microvascular Health – Investigated for effects on vascular function and tissue perfusion.

? Non-Hematopoietic Action – Designed to provide tissue-protective signalling without increasing red blood cell production or hematocrit, unlike erythropoietin. (peptidescholar.com)

Mechanism of Action

ARA-290 selectively binds to the Innate Repair Receptor (IRR), a receptor complex activated during tissue injury and inflammation. Activation of this pathway has been shown in preclinical and early clinical research to promote anti-inflammatory, anti-apoptotic and tissue-protective signalling while avoiding the erythropoietic effects associated with full-length EPO. (peptidescholar.com)

Areas of Ongoing Research

Current scientific research has explored ARA-290 in relation to:

• Peripheral neuropathy
• Small fibre neuropathy
• Diabetic nerve complications
• Tissue protection
• Inflammatory conditions
• Recovery following injury
• Microvascular function
• Neuroprotection

Research Use Only

This product is supplied strictly for laboratory research purposes only.

Not intended for human consumption or therapeutic use.

Gold Star Labs products are manufactured to the highest research standards, with a commitment to purity, quality and consistency for scientific investigation.

Research Use Only

This product is supplied strictly for laboratory research purposes only.

Not intended for human consumption or therapeutic use.

Gold Star Labs products are manufactured to the highest research standards, with a commitment to purity, quality and consistency for scientific investigation.